- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05624970
the Effect of Aerobic Training on Insulin Sensitivity on Diabetic Patients During Tobacco Cessation
the Effect of Steady State Aerobic Training on Insulin Sensitivity on Diabetic Patients During Tobacco Cessation
- Prevalence of smoking in men and women ages 15 and over who currently smoke any tobacco product on a daily or non-daily basis Egypt smoking rate for 2018 was 21.40%, a 0.1% increase from 2016.
- According to WHO reports, smoking is currently responsible for six million premature deaths every year, of which 600 000 individuals die from the effects of second-hand smoke.
- Egypt is one of the 21 countries and territories of the International Diabetes Federation Middle East and North Africa (MENA) region. 463 million people have diabetes in the world and 55 million people in the MENA Region; by 2045 this will rise to 108 million.
- The most profound impact of smoking in diabetic patients is on insulin sensitivity, Cigarette smoking worsens insulin-resistance in patients with diabetes, as smoking decreases subcutaneous absorption of insulin, resulting in increased dosing requirements. When the action of insulin is impaired chronically in smokers, a dose response relationship can be seen between the number of cigarettes smoked and the degree of insulin resistance. Consequently, quitting smoking should improve glycemic control.
- Therefore diabetic patients can get huge benefits from tobacco cessation as they give their bodies chance to decrease percentage of nicotine and increase percentage of insulin so decrease risk of getting atherosclerosis, so smoking cessation improve glycemic control and insulin sensitivity.
Study Overview
Status
Conditions
Detailed Description
Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. Ongoing diabetes self-management education and support are critical to preventing acute complications and reducing the risk of long-term complications.
Nowadays, the harmful effect of smoking is no secret to anyone, unfortunately it is still causes the loss of lives for many adults and young peoples. The Ministry of Health (MOH) seeks to control it and help smokers to quit to save their lives and protect them against smoking-caused diseases such as smoking slows down lung growth in children and teens, increases a person's risk of getting tuberculosis, increases the risk of developing type2 diabetes, also most of COPD (Chronic Obstructive Pulmonary Disease) deaths are a result of smoking. The term "smoking" is not restricted to cigarette smoking only, but includes e-cigarette, shisha and others.
Although cigarette smoking is the leading avoidable cause of death, its specific effects on people with diabetes are even more intricate and profound, thus the macrovascular and microvascular complications become more quickly in smokers with diabetes, and risk of mortality increases. The increased blood pressure and altered lipid profiles in smokers with diabetes could encourage development of the insulin resistance syndrome, setting patients up for further cardiovascular problems.
One of the biggest problems for most patients undergoing a cessation program is the fear of withdrawal symptoms, including cravings, anxiety, depression, irritability, sleep disturbances, increased hunger and weight gain.
Aerobic exercise program for type 2 diabetic has showed great effects not only on glycemic control, blood lipid profiles profile, but also on reducing metabolic risk factors for cardiovascular diseases including insulin resistance. Previous studies have showed the effects of moderate-intensity exercise on the improvement of insulin sensitivity.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alaa Naguib, Ass. lect.
- Phone Number: 01092224967
- Email: alaanaguib10@gmail.com
Study Contact Backup
- Name: Nesreen Elnahas, professor
- Phone Number: 01002227242
- Email: Nesreen_2512@yahoo.com
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Alaa mohamed Naguib
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
According to the following:
- All patients will be male.
- Their age between 40-50 years old
- Their BMI 18.5-29.9 kg/m2
- They are diagnosed as type II diabetes for more than 5 years
- Their HbA1c value from > 6.5%
- Smokers for more than10-15 years
- Their smoking index will be moderate and heavy
- All patients are under full medical supervision
- All patients will quit smoking 1-7 days before undergoes aerobic training program
Exclusion Criteria:
All patients will not have:
- Any patient is known to have any unstable medical condition.
- Any musculoskeletal or neurological disorder
- Hepatic diseases.
- Kidney disorders
- Type I diabetes mellitus
- Type II insulin
- Uncontrolled hypertension
- Unstable angina pectoris
- Uncompensated heart failure
- Recent myocardial infarction
- Heart block
- Cerebrovascular disease
- Anemia
- Patients whose smoking index light
- Tobacco smokers less than 20 years
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: group (A)
Group (A): This group will consist of 30 patients who will receive the medical treatment (oral hypoglycemic drugs), aerobic training, tobacco cessation program and nutritional advices for 12 weeks. |
|
Experimental: group (B)
Group (B): This group will consist of 30 patients who will receive the medical treatment (oral hypoglycemic drugs), tobacco cessation program and nutritional advices for 12 weeks. |
Tobacco Cessation Programs for 3 months Nutritional advices according to American Diabetes Association (ADA) 2015: for 3 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
insulin sensitivity
Time Frame: 3 months
|
The Homeostasis Model Assessment (HOMA): HOMA-IR = [(Fasting Insulin (µU/mL)) X (Fasting Glucose (mmol/L))]/22.5 |
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
assessment of glycemic control
Time Frame: 3 months
|
HbA1c
|
3 months
|
blood pressure
Time Frame: 3 months
|
Normal blood pressure: systolic < 140 mmHg, diastolic <90 mmHg
|
3 months
|
heart rate
Time Frame: 3 months
|
Normal resting heart rate 60-90 beats per minute
|
3 months
|
respiratory rate
Time Frame: 3 months
|
Normal respiratory rate for healthy adults is between 12 and 20 breaths per minute.
|
3 months
|
oxygen saturation
Time Frame: 3 months
|
A pulse oximeter can measure oxygen saturation.
The generally accepted standard is that a normal resting oxygen saturation of less than 95% is considered abnormal
|
3 months
|
ankle brachial index
Time Frame: 3 months
|
The ankle-brachial index (ABI) is the ratio of the systolic blood pressure (SBP) measured at the ankle to that measured at the brachial artery, it was shown that the ABI is an indicator of atherosclerosis and peripheral arterial disease(PAD) The ABI threshold most commonly used is ≤0.90.
|
3 months
|
smoking abstintent questionnaire
Time Frame: 3 months
|
The Smoking Abstinence Questionnaire, appears to capture reliably smokers' expectancies for abstinence (Withdrawal, Social Improvement/Non-smoker Identity, Adverse Outcomes, Common Reasons, Optimistic Outcomes, Coffee Use, and Weight Gain) and expectancies related to the success of a quit attempt (Treatment Effectiveness, Barriers to Treatment and Social Support).
It remains to be seen how far any of these expectancies predict attempts to quit, withdrawal, treatment utilization and response and quitting success above and beyond existing measures.
|
3 months
|
smoking index
Time Frame: 3 months
|
cigarette per day multiplied by years of smoking
|
3 months
|
A body shape index (ABSI)
Time Frame: 3 months
|
WC divided by (BMI 2/3 multiplied by height 1/2)
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Nesreen Elnahas, professor, Cairo Univeristy
- Study Director: Rana elbanaa, lecturer, Cairo Univeristy
- Study Director: Yasmine mohamed, lectuere, Cairo Univeristy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/003343
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Zhejiang Provincial People's HospitalNot yet recruitingType2 Diabetes | type1diabetesChina
Clinical Trials on aerobic training , tobacco cessation and nutritional advices
-
Institut Català d'OncologiaInstituto Oncológico del Oriente Boliviano; Instituto de Cancerología y Hospital... and other collaboratorsCompletedSmoking | Smoking Cessation
-
Cairo UniversityCompleted
-
US Department of Veterans AffairsUniversity of Maryland; National Institutes of Health (NIH); National Institute...CompletedType 2 Diabetes Mellitus | Impaired Glucose Tolerance (Prediabetes)United States
-
University of RochesterNational Cancer Institute (NCI)CompletedTobacco Use Cessation | Second Hand Tobacco SmokeDominican Republic
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCurrent Every Day Smoker | Cigarette SmokerUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingTobacco-Related CarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedTobacco Use | Breast Carcinoma | Head and Neck Carcinoma | Lung Carcinoma | Prostate Carcinoma | CaregiverUnited States
-
IRCCS Policlinico S. MatteoCompleted
-
Maharishi Markendeswar University (Deemed to be...Not yet recruitingPolycystic Ovary Syndrome | Anti-Mullerian Hormone Deficiency | Female Infertility EndocrineIndia
-
Tata Memorial HospitalDepartment of Atomic EnergyCompleted